MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma
about
Ochratoxin A-mediated DNA and protein damage: roles of nitrosative and oxidative stresses.Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin aPerturbation of mitosis through inhibition of histone acetyltransferases: the key to ochratoxin a toxicity and carcinogenicity?MicroRNA profiling of rats with ochratoxin A nephrotoxicity.Atypical roles for Campylobacter jejuni amino acid ATP binding cassette transporter components PaqP and PaqQ in bacterial stress tolerance and pathogen-host cell dynamics.Mechanisms of Mycotoxin-induced Dermal Toxicity and Tumorigenesis Through Oxidative Stress-related PathwaysOchratoxin A activates opposing c-MET/PI3K/Akt and MAPK/ERK 1-2 pathways in human proximal tubule HK-2 cells.The food contaminant and nephrotoxin ochratoxin A enhances Wnt1 inducible signaling protein 1 and tumor necrosis factor-α expression in human primary proximal tubule cells.Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model.Apoptosis signal-regulating kinase 1 promotes Ochratoxin A-induced renal cytotoxicity.Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.Toxicity study of ochratoxin A using HEK293 and HepG2 cell lines based on microRNA profiling.Exposure to Penicillium mycotoxins alters gene expression of enzymes involved in the epigenetic regulation of bovine macrophages (BoMacs).MAPKs' status at early stages of renal carcinogenesis and tumors induced by ferric nitrilotriacetate.
P2860
Q33438813-C0BE0AF5-BA64-4CC4-B7A2-F1FBFC773F46Q35101972-6F3128E7-B4BB-4944-B945-4C1F58C2907BQ35161418-934B89B6-2928-4F4B-B760-523C2956E2DAQ35178777-52696417-8BD5-48C8-9292-5CDC72016641Q37410258-FB62E704-E943-4C7B-A914-496FF42E6A29Q37723939-C4689BF7-017F-43C8-A684-6D90A1E4FECBQ38977350-FC095B2B-F67F-4703-9423-B06CDC18B71FQ39317298-E4BBD208-393B-461D-AE12-C4A82477A8FDQ39436073-8EC0DBB3-E518-4CEE-B8CC-6E8FF255DDB9Q41767470-6775882E-9BCC-471C-9E59-18F9D1C8A60CQ42714145-0D12C3A6-39BF-4C0C-994B-1B617A4E50CEQ50532322-F1C3D556-E767-4593-8B64-3CB34177E0B9Q54249502-A677DC66-8E72-4E8E-B938-47386D8A0FD6Q54287683-A984154B-530F-4B5E-9A85-E445C493EECC
P2860
MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma
description
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Oktober 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/10/15)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/10/15)
@nl
наукова стаття, опублікована в жовтні 2007
@uk
مقالة علمية (نشرت في 15-10-2007)
@ar
name
MAPK-ERK activation in kidney ...... t incidence of renal carcinoma
@ast
MAPK-ERK activation in kidney ...... t incidence of renal carcinoma
@en
MAPK-ERK activation in kidney ...... t incidence of renal carcinoma
@nl
type
label
MAPK-ERK activation in kidney ...... t incidence of renal carcinoma
@ast
MAPK-ERK activation in kidney ...... t incidence of renal carcinoma
@en
MAPK-ERK activation in kidney ...... t incidence of renal carcinoma
@nl
prefLabel
MAPK-ERK activation in kidney ...... t incidence of renal carcinoma
@ast
MAPK-ERK activation in kidney ...... t incidence of renal carcinoma
@en
MAPK-ERK activation in kidney ...... t incidence of renal carcinoma
@nl
P2093
P1476
MAPK-ERK activation in kidney ...... t incidence of renal carcinoma
@en
P2093
B. Schilter
C. Bezençon
C. Verguet
M. Marin-Kuan
S. Nestler
T. Delatour
P304
P356
10.1016/J.TAAP.2007.06.014
P577
2007-10-15T00:00:00Z